GlassScriptPhysician profile
Amanda J Miles
NPI 1477810851
$1,463.87
in general payments reported to CMS, 2019-2025
26 companies · $336 in 2025
The $336 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $40.94 · 2021: $268 · 2022: $197 · 2023: $182 · 2024: $239 · 2025: $336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $757.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $756.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $250.97 | 2023-2025 | Veozah |
| Abbvie INC. | $205.18 | 2019-2023 | |
| Intuitive Surgical, INC. | $148.85 | 2020-2022 | |
| Hologic Sales and Service, LLC | $122.96 | 2023-2025 | Fluent Fluid Management System, Myosure Tissue Removal Device, Aptima |
| Dexcom, INC. | $97.30 | 2025 | Dexcom G6 Transmitter |
| Mayne Pharma Commercial LLC | $85.03 | 2022-2025 | |
| Mission Pharmacal Company | $84.46 | 2019 | |
| Daiichi Sankyo INC. | $82.98 | 2019-2024 | Injectafer |
| Merck Sharp & Dohme LLC | $38.63 | 2019-2021 | |
| Exeltis, USA INC. | $38.02 | 2024-2025 | Slynd |
| Pfizer INC. | $36.60 | 2022-2025 | |
| Organon LLC | $32.48 | 2024-2025 | Nexplanon |
| Axonics, INC. | $26.25 | 2023 | Bulkamid |
| Minerva Surgical, INC | $23.11 | 2023 | |
| Meditrina | $19.84 | 2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $19.60 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.16 | 2019 | |
| Evofem Biosciences, INC. | $17.35 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $17.18 | 2021 | |
| Nestle Healthcare Nutrition INC. | $16.13 | 2021 | |
| Lilly USA, LLC | $14.75 | 2021 | |
| Ethicon US, LLC | $14.13 | 2025 | Stratafix |
| Amgen INC. | $14.08 | 2024 | Prolia, Evenity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.81 | 2019 | |
| Avanos Medical | $13.46 | 2020 | |
| Currax Pharmaceuticals LLC | $11.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Miles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.